Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Gastro-enteropancreatic neuroendocrine tumor × Cisplatin × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 64 Squamous Cell Carcinoma of Head and Neck 35 Lung Neoplasms 30 Urinary Bladder Neoplasms 19 Oropharyngeal Neoplasms 14 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Nasopharyngeal Carcinoma 12 Carcinoma 12 Biliary Tract Neoplasms 12 Esophageal Squamous Cell Carcinoma 11 Ovarian Neoplasms 10 Head and Neck Neoplasms 10 Colorectal Neoplasms 10 Uterine Cervical Neoplasms 9 Neoplasm Metastasis 9 Laryngeal Neoplasms 9 Carcinoma, Squamous Cell 9 Mouth Neoplasms 8 Mesothelioma, Malignant 8 Esophageal Neoplasms 8 Carcinoma, Transitional Cell 8 Hypopharyngeal Neoplasms 7 Stomach Neoplasms 6 Cholangiocarcinoma 6 Neoplasms 5 Gallbladder Neoplasms 5 Pancreatic Neoplasms 4 Medulloblastoma 4 Fallopian Tube Neoplasms 4 Breast Neoplasms 4

Interventions

lutetium Lu 177 dotatate 3 pasireotide 2 Octreotide 2 lanreotide 1 copper dotatate CU-64 1 abemaciclib 1 Sunitinib 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Lutetium-177 1 Lutetium 1 Everolimus 1 E-7386 1 Cryotherapy 1 Acupuncture Therapy 1 Acupressure 1 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡